In recent years, the United Kingdom has witnessed a marked increase in the prescription of cannabis-based medicinal products (CBMPs). Approved for conditions such as chronic pain, epilepsy, and multiple sclerosis, these products represent a significant shift in how healthcare providers approach complex, long-term health conditions. However, alongside this medical evolution comes an important legal and forensic challenge: the growing incidence of drug driving associated with prescribed cannabis.
Prescribed Cannabis: A Legal and Medical Landscape
Since November 2018, specialist doctors in the UK have been legally permitted to prescribe CBMPs. A multitude of products are now part of legitimate treatment plans and many contain tetrahydrocannabinol (THC) – a psychoactive component of cannabis which is also classified as a controlled drug under the Misuse of Drugs Act 1971.
THC can impair cognitive and motor functions, potentially affecting driving performance. Importantly, the law does not distinguish between recreational and prescribed cannabis when it comes to driving under the influence.
Drug Driving Law in the UK
Under Section 5A of the Road Traffic Act 1988, it is illegal to drive with certain controlled drugs in your body above specified limits. For THC, the limit is 2 micrograms per litre of blood — a threshold low enough that even minimal usage can exceed it. Crucially, this law is a “zero-tolerance” approach, meaning prosecution can occur without proving impairment if the threshold is surpassed.
For those using prescribed cannabis, a statutory “medical defence” exists. However, this defence is conditional:
– The drug must have been lawfully prescribed.
– The driver must be taking the medication in accordance with medical advice.
– The driver must not be impaired while driving.
Even if a person has a legitimate prescription, they can still be charged if found to be impaired behind the wheel.
The Forensic Challenge
As a leading forensic science provider, Bericon Forensics has seen a surge in cases where prescribed cannabis use intersects with allegations of drug driving. This raises complex forensic questions:
– Was the driver impaired at the time of the incident?
– Was the level of THC consistent with prescribed usage, or suggestive of misuse?
– Was the presence of the drug in line with therapeutic dosing, or indicative of recreational consumption?
These questions require nuanced toxicological analysis, expert interpretation, and a deep understanding of both pharmacology and legal thresholds.
Ensuring Fair and Accurate Assessments
At Bericon Forensics, our role is to ensure that scientific evidence is presented clearly and accurately in court. We provide:
– Expert toxicology reports evaluating drug levels in context.
– Interpretation of prescription records and medical notes to support or challenge the “medical defence”.
– Independent opinion on impairment and driving capability based on the latest research.
Our mission is to support justice whether that means defending a legitimate prescription user wrongfully accused or providing clarity in cases of misuse.
Conclusion
The increased use of prescribed cannabis in the UK is a positive step for many patients, but it also introduces new legal and forensic complexities. Drivers must be made aware that even prescribed use can lead to legal consequences if impairment occurs or limits are exceeded. As forensic scientists, our responsibility is to provide clear, impartial, and scientifically robust insight into each case.
For expert forensic support in drug driving cases, contact Bericon Forensics.
